Valeant Pharmaceuticals International, Inc. (BHC)

Last Three Months

24-Jan-24 -- 23-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Delivery

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

58

0

3

+1

0

+2

0

+3

Two Year Chart

24-Apr-22 -- 23-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Apr-24 4:29 PM View:	29-Mar-24 Grant $6.86K	Wechsler Amy B Director		Valeant Pharmaceuticals International, Inc. - BHC	0% 169.26K to 169.91K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:30 PM View:	29-Mar-24 Grant $31.25K	Robertson Russel C Director		Valeant Pharmaceuticals International, Inc. - BHC	1% 222.33K to 225.28K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:33 PM View:	29-Mar-24 Grant $62.49K	Paulson John Director		Valeant Pharmaceuticals International, Inc. - BHC	3% 202.42K to 208.31K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:31 PM View:	29-Mar-24 Grant $33.12K	Icahn Brett Director		Valeant Pharmaceuticals International, Inc. - BHC	3% 105.38K to 108.5K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:19 PM View:	01-Mar-24 Payment of Exercise ($1.16M)	Appio Thomas Chief Executive Officer Director		Valeant Pharmaceuticals International, Inc. - BHC	42% 967.01K to 1.37M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:16 PM View:	04-Mar-24 Sale (Planned) ($61.87K)	Carson Seana EVP, General Counsel		Valeant Pharmaceuticals International, Inc. - BHC	31% 382.93K to 499.9K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:24 PM View:	01-Mar-24 Payment of Exercise ($31.53K)	Barresi John S SVP, Controller & CAO		Valeant Pharmaceuticals International, Inc. - BHC	51% 71.13K to 107.06K	0	0	--	--	Show Txns Hide Txns